USFDA Approves Granules Pharmaceuticals’ Generic Vyvanse Chewables
Granules Pharmaceuticals, Inc. has successfully received USFDA approval for its bioequivalent generic version of Lisdexamfetamine Dimesylate Chewable Tablets…
Granules Pharmaceuticals, Inc. has successfully received USFDA approval for its bioequivalent generic version of Lisdexamfetamine Dimesylate Chewable Tablets…
The essay captures the transformative impact of science on various aspects of human life, emphasizing its pivotal role…
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for Amgen’s Blincyto (blinatumomab), expanding…
🔷Cipla has launched India’s first inhalable insulin, Afrezza, after receiving approval from the Central Drugs Standard Control Organisation…
The tumor microenvironment (TME) is indeed a critical determinant of cancer progression and immune evasion. Its dynamic and…
♦️Cancer cells use complex mechanisms to evade immune surveillance, with inhibition of apoptotic signaling being a key strategy.…
The advancements in pharmaceutical manufacturing technologies, particularly in media fill testing, represent a significant leap forward in ensuring…
Global Orally Disintegrating Tablet Market Overview: An Orally Disintegrating Tablet is a drug dosage form available for a…
Lupin Limited, a prominent global pharmaceutical company, has announced that its Research and Development facility at the Lupin…
The development of ammonia-powered engines has taken a significant step forward with the commencement of full-scale testing of…